Skip to main content
. 2014 Jun;55(6):1019–1032. doi: 10.1194/jlr.M039925

TABLE 3.

Pharmacokinetic profile of rohitukine after oral (50 mg/kg) and intravenous (5 mg/kg) administration (n = 3)

Estimates (mean ± SD)
Parameters Oral (50 mg/kg) Intravenous (5 mg/kg)
Cmax (µg/ml) 6.62 ± 0.66 5.37 ± 2.12
Tmax (h) 0.25
AUC0–∞ (µg * h/ml) 10.66 ± 2.34 4.14 ± 1.08
MRT (h) 6.64 ± 1.39 7.07 ± 3.02
Fabs (%) 25.7

AUC, area under the curve from 0 to ∞ h; Cmax, maximum concentration; Fabs, absolute bioavailability; MRT, mean residence time; Tmax, time of maximum concentration.